Q2 2020 Jubilant Life Sciences Ltd Earnings Call Transcript
Ladies and gentlemen, good day, and welcome to the Jubilant Life Sciences Limited Earnings Conference Call. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. Ravi Agrawal, Head of Investor Relations. Thank you, and over to you, Mr. Agrawal.
Yes. Thank you. Good evening, everybody. I'm Ravi Agrawal, Head of Investor Relations at Jubilant Life Sciences. I thank you again for being with us today on our Q2 and H1 FY '20 earnings conference call.
I would like to remind you that some of the statements made on the call today could be forward-looking in nature, and a detailed disclaimer in this regard has been included in the press release that has been shared on our website.
On the call today, we have Mr. Shyam Bhartia, Chairman; Mr. Hari S. Bhartia, Co-Chairman and Managing Director; Mr. R. Sankaraiah, Executive Director of Finance; Mr. Pramod Yadav, CEO, Jubilant Pharma; and Mr. Rajesh Srivastava, CEO, LSI, Life
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
